UK Markets open in 3 hrs 41 mins

Kanabo Group Plc (KNB.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
17.75-0.25 (-1.39%)
At close: 4:26PM BST
Full screen
Previous close18.00
Open18.10
Bid17.00 x N/A
Ask18.50 x N/A
Day's range17.00 - 18.50
52-week range4.65 - 51.00
Volume407,308
Avg. volume724,667
Market cap65.41M
Beta (5Y monthly)0.91
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Business Wire

    Kanabo Signs Agreement to Acquire Materia and Create Europe’s Largest Public Cannabis Company

    LONDON, July 26, 2021--Kanabo Group Plc (LSE:KNB) ("Kanabo" or the "Company"), the first medical cannabis company to IPO on London Stock Exchange, has signed a Letter of Intent to acquire Materia, a leading processor and distributor of medical cannabis and CBD wellness products across Europe.

  • Business Wire

    Kanabo to Deliver First Medical Grade Cannabis Extract Vape Formulas in the UK

    LONDON, July 14, 2021--Kanabo, the first medicinal cannabis company to IPO on London Stock Exchange, will be delivering its medicinal cannabis formula to the UK this month, as scheduled. The deal with LYPHE Group means that thousands of patients will be the first in Europe to have access to pain relief delivered in a metered dose via Kanabo’s VapePod.

  • Business Wire

    Kanabo Appoints Dr Daniel Poulter MP as Non-Executive Director

    LONDON, June 29, 2021--Medical cannabis R&D company, Kanabo Group Plc, today announced that it has appointed Dr Dan Poulter MP as a Non-Executive Director to the board. As both a former UK Government health minister, and as the chairperson of the All-Party Parliamentary Group for Global Health, Dr Poulter has a detailed knowledge of the drugs and medicines regulatory framework in the UK. His blend of medical, governmental, and healthcare policy experience makes him well positioned to support Kan